Petmed Express Inc (NASDAQ:PETS) Institutional Investors 2017 Q4 Sentiment

April 17, 2018 - By Winifred Garcia

PetMed Express, Inc. (NASDAQ:PETS) Logo

Sentiment for Petmed Express Inc (NASDAQ:PETS)

Petmed Express Inc (NASDAQ:PETS) institutional sentiment decreased to 1.11 in 2017 Q4. Its down -0.27, from 1.38 in 2017Q3. The ratio is negative, as 88 active investment managers increased and opened new holdings, while 79 reduced and sold their equity positions in Petmed Express Inc. The active investment managers in our partner’s database now possess: 17.75 million shares, down from 19.66 million shares in 2017Q3. Also, the number of active investment managers holding Petmed Express Inc in their top 10 holdings increased from 1 to 2 for an increase of 1. Sold All: 36 Reduced: 43 Increased: 46 New Position: 42.

PetMed Express, Inc. and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company has market cap of $764.00 million. The firm markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats to retail customers. It has a 22.06 P/E ratio. It provides non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, thyroid, diabetes, pain medications, antibiotics, and other specialty medications, as well as generic substitutes.

The stock increased 1.38% or $0.51 during the last trading session, reaching $37.51. About 225,938 shares traded. PetMed Express, Inc. (NASDAQ:PETS) has risen 108.30% since April 17, 2017 and is uptrending. It has outperformed by 96.75% the S&P500.

Analysts await PetMed Express, Inc. (NASDAQ:PETS) to report earnings on May, 14. They expect $0.44 EPS, up 18.92 % or $0.07 from last year’s $0.37 per share. PETS’s profit will be $8.96M for 21.31 P/E if the $0.44 EPS becomes a reality. After $0.44 actual EPS reported by PetMed Express, Inc. for the previous quarter, Wall Street now forecasts 0.00 % EPS growth.

Gratia Capital Llc holds 3.54% of its portfolio in PetMed Express, Inc. for 310,475 shares. Oaktop Capital Management Ii L.P. owns 373,675 shares or 3.42% of their US portfolio. Moreover, U S Global Investors Inc has 0.88% invested in the company for 42,600 shares. The New Jersey-based Landscape Capital Management L.L.C. has invested 0.67% in the stock. North Star Investment Management Corp., a Illinois-based fund reported 95,842 shares.#img1#

Since January 1, 0001, it had 0 insider buys, and 5 insider sales for $3.80 million activity.

PetMed Express, Inc. (NASDAQ:PETS) Ratings Coverage

Ratings analysis reveals 50% of Petmed Express’s analysts are positive. Out of 2 Wall Street analysts rating Petmed Express, 1 give it “Buy”, 0 “Sell” rating, while 1 recommend “Hold”. The lowest target is $58.0 while the high is $61.0. The stock’s average target of $61 is 62.62% above today’s ($37.51) share price. PETS was included in 3 notes of analysts from October 27, 2017. Northcoast maintained the stock with “Buy” rating in Wednesday, January 3 report. The company was maintained on Friday, October 27 by Noble Financial. The stock has “Buy” rating by Northcoast on Friday, January 19.

PetMed Express, Inc. (NASDAQ:PETS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: